Abstract

I firmly believe that vitiligo is an autoimmune disease in which autoreactive, melanocyte-specific cytotoxic T lymphocytes (CTL) escape central tolerance, break peripheral tolerance and destroy epidermal melanocytes. The evidence in favour of the autoimmune genesis of vitiligo is highly convincing. Suppression of immune reactivity by various effective treatments suggests that their immunosuppressive mechanism interferes with that which leads to the destruction of melanocytes (1-6). The association of vitiligo with other autoimmune diseases is well known (7-9). The presence of circulating anti-melanocyte antibodies points to a possible involvement of humoral immunity, while the involvement of cellular immunity is indicated by lymphocyte infiltration at the margin of lesions. In particular, the presence of cellular infiltrates during the progressive loss of melanocytes from depigmenting vitiligo skin (10) and the detection of T cells juxtapositionally apposed to remaining melanocytes (11) demonstrate the early implication of cellular immunity in the pathogenesis of the disease. Other views, however, exist. Intrinsically increased sensitivity of melanocytes to oxidative stress is said to be pathogenic. This, however, can be no more than a conjecture in the total absence of any experimental demonstration that it is a primary event. Fault can also be found with the postulation of an inappropriate reaction to neuropeptides as the leading cause. Their concentration in vitiligo skin is not sufficient to kill melanocytes, while the time course of their production is such as to rank them as a consequence rather than a cause (12). These and other proposed pathogenetic mechanisms have very little to offer in the way of proof. The point is ‘what immune cells are pathogenic? Melanocyte-specific autoantibodies are certainly present (13-17), but their pathogenic role is a mystery. The patchy distribution of cutaneous depigmentation and the very frequent symmetrical distribution of lesions fit in well with the view that autoimmune melanocyte destruction is induced by lymphocyte clones with affinities for specific areas of skin (18). We and others (19-21) have demonstrated the presence of high frequencies of melanocyte-specific CTL in the peripheral blood of patients with vitiligo. These autoreactive CTL are functionally intact and kill normal melanocytes in vitro. They display high avidity of antigen recognition and express the skin-homing receptor CLA (22). Overall, these findings strongly support an association between the presence of melanocyte-specific CTL and vitiligo, and directly point to their pathogenic role in this disease. Investigation of the association of vitiligo with melanoma has clarified the role of autoreactive CTL in its development. Identical clonally expanded CTL have been detected in a regressing melanoma and in the vitiligo-like halo surrounding the tumor (23). These and other findings assume that antigen-specific proliferation is involved in the destruction of normal and malignant melanocytes (24-26). Work from our group has contributed to the current opinion that vitiligo T cells demonstrate reactivity to antigens previously recognized as target antigens for T cells infiltrating melanoma tumors (20, 22, 27). Interestingly, in a comparison with melanoma-derived T cells, vitiligo T cells displayed greater reactivity towards melanoma cells (28). We believe that high avidity of antigen recognition represents a peculiar property of anti-melanocytic CTL from patients with vitiligo that contributes to their abnormal reactivity (29). In conclusion, melanocyte-specific CTL with high-affinity T-cell receptors most likely escape clonal deletion in the thymus and enter the circulation. By expressing CLA, they home to the skin where they express type 1 cytokine profiles and mediate melanocyte destruction. The immunological imbalances thus created may be supposed to herald the processes that also initiate a biochemical or neural mechanism for the destruction of melanocytes. Cellular autoimmunity can therefore be proposed as the sole cause and origin of vitiligo.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.